Literature DB >> 12147662

Distribution of cervical glandular intraepithelial neoplasia: are hysterectomy specimens sampled appropriately?

M K Heatley1.   

Abstract

AIMS: To establish the validity of assuming that by examining midline blocks from the anterior and posterior lips of the cervix, a previously unsuspected cervical intraepithelial glandular neoplasia (CIGN) lesion would be identified.
METHODS: The distribution of CIGN in 30 cone biopsy specimens of cervix was examined.
RESULTS: Nine low grade and 21 high grade cases were identified involving one or other lip in 29 patients and one or both lateral edges in 20. The distribution of CIGN was unifocal in 20 patients, involved two distinct foci in nine, and three distinct foci in one. Only three patients had a circumferential distribution. Midline disease, either CIGN or squamous cervical intraepithelial neoplasia (CIN), or both, was present in 27 patients.
CONCLUSION: These findings suggest that examining the midline blocks from hysterectomy specimens will result in the identification of CIGN lesions in over 90% of patients, either because the CIGN lesion is present in the midline or because an associated squamous CIN lesion will be identified, which will result in the examination of the entire cervix, with the consequent identification of the CIGN lesion.

Entities:  

Mesh:

Year:  2002        PMID: 12147662      PMCID: PMC1769728          DOI: 10.1136/jcp.55.8.629

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  The anatomical distribution of intraepithelial epidermoid carcinomas of the cervix.

Authors:  F W FOOTE; F W STEWART
Journal:  Cancer       Date:  1948-09       Impact factor: 6.860

2.  Distribution of cervical intraepithelial neoplasia: are hysterectomy specimens sampled appropriately?

Authors:  M Heatley
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

3.  The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.

Authors:  N S Goldstein; A Mani
Journal:  Am J Clin Pathol       Date:  1998-06       Impact factor: 2.493

4.  Adenocarcinoma in situ of the uterine cervix: management and outcome.

Authors:  T Widrich; A W Kennedy; T M Myers; W R Hart; S Wirth
Journal:  Gynecol Oncol       Date:  1996-06       Impact factor: 5.482

5.  The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment.

Authors:  M Bertrand; G M Lickrish; T J Colgan
Journal:  Am J Obstet Gynecol       Date:  1987-07       Impact factor: 8.661

6.  Adenocarcinoma in situ of the cervix.

Authors:  A G Ostör; R Pagano; R A Davoren; D W Fortune; W Chanen; R Rome
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

7.  Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases.

Authors:  E S Andersen; E Arffmann
Journal:  Gynecol Oncol       Date:  1989-10       Impact factor: 5.482

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.